These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8912858)

  • 1. Effect of charge on the interaction of site-specific photoimmunoconjugates with human ovarian cancer cells.
    Hamblin MR; Miller JL; Hasan T
    Cancer Res; 1996 Nov; 56(22):5205-10. PubMed ID: 8912858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer.
    Duska LR; Hamblin MR; Bamberg MP; Hasan T
    Br J Cancer; 1997; 75(6):837-44. PubMed ID: 9062404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted photodestruction of human colon cancer cells using charged 17.1A chlorin e6 immunoconjugates.
    Del Governatore M; Hamblin MR; Piccinini EE; Ugolini G; Hasan T
    Br J Cancer; 2000 Jan; 82(1):56-64. PubMed ID: 10638967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal photoimmunotherapy of ovarian carcinoma xenografts in nude mice using charged photoimmunoconjugates.
    Molpus KL; Hamblin MR; Rizvi I; Hasan T
    Gynecol Oncol; 2000 Mar; 76(3):397-404. PubMed ID: 10684717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent modifications of antitetanus F(ab')2 fragments with natural and synthetic polyamines and their effects on the antibody endocytosis in cultured HL60 cells.
    Hervé F; Ghinea N; D'Athis P; Carrupt PA; Scherrmann JM
    Bioconjug Chem; 2008 Aug; 19(8):1543-55. PubMed ID: 18630939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegylated polyethylenimine-Fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells.
    Merdan T; Callahan J; Petersen H; Kunath K; Bakowsky U; Kopecková P; Kissel T; Kopecek J
    Bioconjug Chem; 2003; 14(5):989-96. PubMed ID: 13129403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degree of substitution of chlorin e6 on charged poly-L-lysine chains affects their cellular uptake, localization and phototoxicity towards macrophages and cancer cells.
    Hamblin MR; Miller JL; Rizvi I; Ortel B
    J Xray Sci Technol; 2002 Jan; 10(3):139-52. PubMed ID: 22388044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photoimmunotherapy of human ovarian carcinoma cells ex vivo.
    Goff BA; Bamberg M; Hasan T
    Cancer Res; 1991 Sep; 51(18):4762-7. PubMed ID: 1716512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced cellular uptake and transport of polyclonal immunoglobulin G and fab after their cationization.
    Hong G; Chappey O; Niel E; Scherrmann JM
    J Drug Target; 2000; 8(2):67-77. PubMed ID: 10852339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates.
    Savellano MD; Pogue BW; Hoopes PJ; Vitetta ES; Paulsen KD
    Cancer Res; 2005 Jul; 65(14):6371-9. PubMed ID: 16024640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin G, F(AB')2, and fab fragment uptake kinetics in isolated perfused rat liver and rat hepatic cells.
    Bazin-Redureau M; Gires P; Chapelle P; Martinet M; Scherrmann JM
    Drug Metab Dispos; 1995 Dec; 23(12):1400-6. PubMed ID: 8689951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
    Tahtis K; Lee FT; Smyth FE; Power BE; Renner C; Brechbiel MW; Old LJ; Hudson PJ; Scott AM
    Clin Cancer Res; 2001 Apr; 7(4):1061-72. PubMed ID: 11309358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetic characteristics of glycolated humanized anti-Tac Fabs are determined by their isoelectric points.
    Kobayashi H; Le N; Kim IS; Kim MK; Pie JE; Drumm D; Paik DS; Waldmann TA; Paik CH; Carrasquillo JA
    Cancer Res; 1999 Jan; 59(2):422-30. PubMed ID: 9927057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of domain deletion, glycosylation, and long IgG3 hinge on the biodistribution and serum stability properties of a humanized IgG1 immunoglobulin, hLL2, and its fragments.
    Leung SO; Qu Z; Hansen HJ; Shih LB; Wang J; Losman MJ; Goldenberg DM; Sharkey RM
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3106s-3117s. PubMed ID: 10541351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the uptake mechanisms of 99mTc-labeled antibodies by liver tissue.
    Xue LY; Noujaim AA; Sykes TR; Peng Z
    Q J Nucl Med; 1996 Jun; 40(2):176-81. PubMed ID: 8909103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiopropyl-agarose as a solid phase reducing agent for chemical modification of IgG and F(ab')2.
    Ferraz N; Leverrier J; Batista-Viera F; Manta C
    Biotechnol Prog; 2008; 24(5):1154-9. PubMed ID: 19194926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
    Welfringer F; d'Athis P; Scherrmann JM; Hervé F
    J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breaking the selectivity-uptake trade-off of photoimmunoconjugates with nanoliposomal irinotecan for synergistic multi-tier cancer targeting.
    Liang BJ; Pigula M; Baglo Y; Najafali D; Hasan T; Huang HC
    J Nanobiotechnology; 2020 Jan; 18(1):1. PubMed ID: 31898555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical design of radiolabeled antibody fragments for low renal radioactivity levels.
    Arano Y; Fujioka Y; Akizawa H; Ono M; Uehara T; Wakisaka K; Nakayama M; Sakahara H; Konishi J; Saji H
    Cancer Res; 1999 Jan; 59(1):128-34. PubMed ID: 9892197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.